Vertex Pharmaceuticals (VRTX) Revenue Growth (3y) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 122.97% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 7.94% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 4.47% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 54.05% |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.94% |
| Dec 31, 2025 | 11.48% |
| Sep 30, 2025 | 9.64% |
| Jun 30, 2025 | 10.52% |
| Mar 31, 2025 | 9.72% |
| Dec 31, 2024 | 12.00% |
| Sep 30, 2024 | 11.79% |
| Jun 30, 2024 | 13.84% |
| Mar 31, 2024 | 15.99% |
| Dec 31, 2023 | 15.65% |
| Sep 30, 2023 | 17.31% |
| Jun 30, 2023 | 17.82% |
| Mar 31, 2023 | 16.16% |
| Dec 31, 2022 | 145.41% |
| Sep 30, 2022 | 34.95% |
| Jun 30, 2022 | 32.63% |
| Mar 31, 2022 | 34.69% |
| Dec 31, 2021 | 33.55% |
| Sep 30, 2021 | 36.24% |
| Jun 30, 2021 | 33.59% |
| Mar 31, 2021 | 39.09% |
| Dec 31, 2020 | 35.69% |
| Sep 30, 2020 | 38.57% |
| Jun 30, 2020 | 40.97% |
| Mar 31, 2020 | 28.46% |
| Dec 31, 2019 | -30.23% |
| Sep 30, 2019 | 32.35% |
| Jun 30, 2019 | 30.28% |
| Mar 31, 2019 | 29.19% |
| Dec 31, 2018 | 28.87% |
| Sep 30, 2018 | 37.39% |
| Jun 30, 2018 | 65.45% |
| Mar 31, 2018 | 69.81% |
| Dec 31, 2017 | 65.19% |
| Sep 30, 2017 | 61.56% |
| Jun 30, 2017 | 64.46% |
| Mar 31, 2017 | 82.05% |
| Dec 31, 2016 | 52.70% |
| Sep 30, 2016 | 22.71% |
| Jun 30, 2016 | 18.66% |
| Mar 31, 2016 | 6.63% |
| Dec 31, 2015 | 6.77% |
| Sep 30, 2015 | -3.44% |
| Jun 30, 2015 | -26.50% |
| Mar 31, 2015 | -29.62% |
| Dec 31, 2014 | -36.45% |
| Sep 30, 2014 | -31.12% |
| Mar 31, 2014 | 17.16% |
| Dec 31, 2013 | 25.27% |
| Sep 30, 2013 | 110.42% |
| Jun 30, 2013 | 100.48% |
| Mar 31, 2013 | 144.63% |
| Dec 31, 2012 | 114.40% |
| Sep 30, 2012 | 137.89% |
| Jun 30, 2012 | 179.96% |
| Mar 31, 2012 | 150.16% |